表紙
市場調查報告書

白血球消除療法的全球市場

Leukapheresis

出版商 Global Industry Analysts, Inc. 商品編碼 913409
出版日期 內容資訊 英文 221 Pages
商品交期: 最快1-2個工作天內
價格
白血球消除療法的全球市場 Leukapheresis
出版日期: 2020年07月01日內容資訊: 英文 221 Pages
簡介

本報告提供全球白血球消除療法市場相關調查分析,提供市場概要,主要企業,市場趨勢·促進因素,全球市場預測,各地區市場分析,競爭情形相關的系統性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球白血球消除療法市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他歐洲
    • 亞太地區
    • 其他地區

第4章 競爭企業

  • ALLCELLS LLC
  • 旭化成醫學
  • BIOIVT
  • CALTAG MEDSYSTEMS LIMITED
  • FRESENIUS SE & CO. KGAA
  • HAEMONETICS CORPORATION
  • HEMACARE CORPORATION
  • KEY BIOLOGICS, LLC.
  • MACOPHARMA SA
  • PPA RESEARCH GROUP, INC.
  • PRECISION MEDICINE GROUP
  • STEMCELL TECHNOLOGIES
  • STEMEXPRESS
  • Terumo CorporationBCT
  • ZENBIO

第5章 調查資料

目錄
Product Code: MCP12997

Global Leukapheresis Market to Reach $31.9 Million by 2027

Amid the COVID-19 crisis, the global market for Leukapheresis estimated at US$21.2 Million in the year 2020, is projected to reach a revised size of US$31.9 Million by 2027, growing at aCAGR of 6% over the period 2020-2027. Leukapheresis Devices, one of the segments analyzed in the report, is projected to record 6.2% CAGR and reach US$14.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Leukapheresis Disposables segment is readjusted to a revised 5.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.2 Million, While China is Forecast to Grow at 5.6% CAGR

The Leukapheresis market in the U.S. is estimated at US$6.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Million by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.We bring years of research experience to this 9th edition of our report. The 221-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Allcells LLC
  • Asahi Kasei Medical Co., Ltd.
  • BioIVT
  • Caltag Medsystems Limited
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Key Biologics, LLC.
  • MacoPharma SA
  • Ppa Research Group, Inc.
  • Precision Medicine Group, Inc.
  • StemCell Technologies Inc.
  • StemExpress
  • Terumo BCT, Inc.
  • Zenbio, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Leukapheresis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Leukapheresis Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 2: Leukapheresis Global Retrospective Market Scenario in US$ by Region/Country: 2012-2019
  • TABLE 3: Leukapheresis Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Leukapheresis Devices (Product) World Market by Region/Country in US$: 2020 to 2027
  • TABLE 5: Leukapheresis Devices (Product) Historic Market Analysis by Region/Country in US$: 2012 to 2019
  • TABLE 6: Leukapheresis Devices (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Leukapheresis Disposables (Product) Potential Growth Markets Worldwide in US$: 2020 to 2027
  • TABLE 8: Leukapheresis Disposables (Product) Historic Market Perspective by Region/Country in US$: 2012 to 2019
  • TABLE 9: Leukapheresis Disposables (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Research (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 11: Research (Application) Retrospective Demand Analysis in US$ by Region/Country: 2012-2019
  • TABLE 12: Research (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Therapeutic (Application) Demand Potential Worldwide in US$ by Region/Country: 2020-2027
  • TABLE 14: Therapeutic (Application) Historic Sales Analysis in US$ by Region/Country: 2012-2019
  • TABLE 15: Therapeutic (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Blood Component Providers & Blood Centers (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 17: Blood Component Providers & Blood Centers (End-Use) Global Historic Analysis in US$ by Region/Country: 2012-2019
  • TABLE 18: Blood Component Providers & Blood Centers (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Academic & Research Institutes (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2020 through 2027
  • TABLE 20: Academic & Research Institutes (End-Use) Analysis of Historic Sales in US$ by Region/Country for the Years 2012 to 2019
  • TABLE 21: Academic & Research Institutes (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ by Region/Country: 2020-2027
  • TABLE 23: Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ by Region/Country: 2012-2019
  • TABLE 24: Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Hospitals & Transfusion Centers (End-Use) Worldwide Sales in US$ by Region/Country: 2020-2027
  • TABLE 26: Hospitals & Transfusion Centers (End-Use) Historic Demand Patterns in US$ by Region/Country: 2012-2019
  • TABLE 27: Hospitals & Transfusion Centers (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Leukapheresis Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 28: United States Leukapheresis Market Estimates and Projections in US$ by Product: 2020 to 2027
    • TABLE 29: Leukapheresis Market in the United States by Product: A Historic Review in US$ for 2012-2019
    • TABLE 30: United States Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 31: United States Leukapheresis Latent Demand Forecasts in US$ by Application: 2020 to 2027
    • TABLE 32: Leukapheresis Historic Demand Patterns in the United States by Application in US$ for 2012-2019
    • TABLE 33: Leukapheresis Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
    • TABLE 34: United States Leukapheresis Latent Demand Forecasts in US$ by End-Use: 2020 to 2027
    • TABLE 35: Leukapheresis Historic Demand Patterns in the United States by End-Use in US$ for 2012-2019
    • TABLE 36: Leukapheresis Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 37: Canadian Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020 to 2027
    • TABLE 38: Canadian Leukapheresis Historic Market Review by Product in US$: 2012-2019
    • TABLE 39: Leukapheresis Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
    • TABLE 40: Canadian Leukapheresis Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
    • TABLE 41: Leukapheresis Market in Canada: Summarization of Historic Demand Patterns in US$ by Application for 2012-2019
    • TABLE 42: Canadian Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 43: Canadian Leukapheresis Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
    • TABLE 44: Leukapheresis Market in Canada: Summarization of Historic Demand Patterns in US$ by End-Use for 2012-2019
    • TABLE 45: Canadian Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 46: Japanese Market for Leukapheresis: Annual Sales Estimates and Projections in US$ by Product for the Period 2020-2027
    • TABLE 47: Leukapheresis Market in Japan: Historic Sales Analysis in US$ by Product for the Period 2012-2019
    • TABLE 48: Japanese Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 49: Japanese Demand Estimates and Forecasts for Leukapheresis in US$ by Application: 2020 to 2027
    • TABLE 50: Japanese Leukapheresis Market in US$ by Application: 2012-2019
    • TABLE 51: Leukapheresis Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
    • TABLE 52: Japanese Demand Estimates and Forecasts for Leukapheresis in US$ by End-Use: 2020 to 2027
    • TABLE 53: Japanese Leukapheresis Market in US$ by End-Use: 2012-2019
    • TABLE 54: Leukapheresis Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 55: Chinese Leukapheresis Market Growth Prospects in US$ by Product for the Period 2020-2027
    • TABLE 56: Leukapheresis Historic Market Analysis in China in US$ by Product: 2012-2019
    • TABLE 57: Chinese Leukapheresis Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 58: Chinese Demand for Leukapheresis in US$ by Application: 2020 to 2027
    • TABLE 59: Leukapheresis Market Review in China in US$ by Application: 2012-2019
    • TABLE 60: Chinese Leukapheresis Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 61: Chinese Demand for Leukapheresis in US$ by End-Use: 2020 to 2027
    • TABLE 62: Leukapheresis Market Review in China in US$ by End-Use: 2012-2019
    • TABLE 63: Chinese Leukapheresis Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Leukapheresis Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 64: European Leukapheresis Market Demand Scenario in US$ by Region/Country: 2020-2027
    • TABLE 65: Leukapheresis Market in Europe: A Historic Market Perspective in US$ by Region/Country for the Period 2012-2019
    • TABLE 66: European Leukapheresis Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 67: European Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020-2027
    • TABLE 68: Leukapheresis Market in Europe in US$ by Product: A Historic Review for the Period 2012-2019
    • TABLE 69: European Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 70: European Leukapheresis Addressable Market Opportunity in US$ by Application: 2020-2027
    • TABLE 71: Leukapheresis Market in Europe: Summarization of Historic Demand in US$ by Application for the Period 2012-2019
    • TABLE 72: European Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 73: European Leukapheresis Addressable Market Opportunity in US$ by End-Use: 2020-2027
    • TABLE 74: Leukapheresis Market in Europe: Summarization of Historic Demand in US$ by End-Use for the Period 2012-2019
    • TABLE 75: European Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 76: Leukapheresis Market in France by Product: Estimates and Projections in US$ for the Period 2020-2027
    • TABLE 77: French Leukapheresis Historic Market Scenario in US$ by Product: 2012-2019
    • TABLE 78: French Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 79: Leukapheresis Quantitative Demand Analysis in France in US$ by Application: 2020-2027
    • TABLE 80: French Leukapheresis Historic Market Review in US$ by Application: 2012-2019
    • TABLE 81: French Leukapheresis Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
    • TABLE 82: Leukapheresis Quantitative Demand Analysis in France in US$ by End-Use: 2020-2027
    • TABLE 83: French Leukapheresis Historic Market Review in US$ by End-Use: 2012-2019
    • TABLE 84: French Leukapheresis Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 85: Leukapheresis Market in Germany: Recent Past, Current and Future Analysis in US$ by Product for the Period 2020-2027
    • TABLE 86: German Leukapheresis Historic Market Analysis in US$ by Product: 2012-2019
    • TABLE 87: German Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 88: Leukapheresis Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2020-2027
    • TABLE 89: German Leukapheresis Market in Retrospect in US$ by Application: 2012-2019
    • TABLE 90: Leukapheresis Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
    • TABLE 91: Leukapheresis Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2020-2027
    • TABLE 92: German Leukapheresis Market in Retrospect in US$ by End-Use: 2012-2019
    • TABLE 93: Leukapheresis Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 94: Italian Leukapheresis Market Growth Prospects in US$ by Product for the Period 2020-2027
    • TABLE 95: Leukapheresis Historic Market Analysis in Italy in US$ by Product: 2012-2019
    • TABLE 96: Italian Leukapheresis Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 97: Italian Demand for Leukapheresis in US$ by Application: 2020 to 2027
    • TABLE 98: Leukapheresis Market Review in Italy in US$ by Application: 2012-2019
    • TABLE 99: Italian Leukapheresis Market Share Breakdown by Application: 2012 VS 2020 VS 2027
    • TABLE 100: Italian Demand for Leukapheresis in US$ by End-Use: 2020 to 2027
    • TABLE 101: Leukapheresis Market Review in Italy in US$ by End-Use: 2012-2019
    • TABLE 102: Italian Leukapheresis Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 103: United Kingdom Market for Leukapheresis: Annual Sales Estimates and Projections in US$ by Product for the Period 2020-2027
    • TABLE 104: Leukapheresis Market in the United Kingdom: Historic Sales Analysis in US$ by Product for the Period 2012-2019
    • TABLE 105: United Kingdom Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 106: United Kingdom Demand Estimates and Forecasts for Leukapheresis in US$ by Application: 2020 to 2027
    • TABLE 107: United Kingdom Leukapheresis Market in US$ by Application: 2012-2019
    • TABLE 108: Leukapheresis Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
    • TABLE 109: United Kingdom Demand Estimates and Forecasts for Leukapheresis in US$ by End-Use: 2020 to 2027
    • TABLE 110: United Kingdom Leukapheresis Market in US$ by End-Use: 2012-2019
    • TABLE 111: Leukapheresis Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020-2027
    • TABLE 113: Leukapheresis Market in Rest of Europe in US$ by Product: A Historic Review for the Period 2012-2019
    • TABLE 114: Rest of Europe Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027
    • TABLE 115: Rest of Europe Leukapheresis Addressable Market Opportunity in US$ by Application: 2020-2027
    • TABLE 116: Leukapheresis Market in Rest of Europe: Summarization of Historic Demand in US$ by Application for the Period 2012-2019
    • TABLE 117: Rest of Europe Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 118: Rest of Europe Leukapheresis Addressable Market Opportunity in US$ by End-Use: 2020-2027
    • TABLE 119: Leukapheresis Market in Rest of Europe: Summarization of Historic Demand in US$ by End-Use for the Period 2012-2019
    • TABLE 120: Rest of Europe Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 121: Leukapheresis Market in Asia-Pacific by Product: Estimates and Projections in US$ for the Period 2020-2027
    • TABLE 122: Asia-Pacific Leukapheresis Historic Market Scenario in US$ by Product: 2012-2019
    • TABLE 123: Asia-Pacific Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027
    • TABLE 124: Leukapheresis Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2020-2027
    • TABLE 125: Asia-Pacific Leukapheresis Historic Market Review in US$ by Application: 2012-2019
    • TABLE 126: Asia-Pacific Leukapheresis Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and 2027
    • TABLE 127: Leukapheresis Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2020-2027
    • TABLE 128: Asia-Pacific Leukapheresis Historic Market Review in US$ by End-Use: 2012-2019
    • TABLE 129: Asia-Pacific Leukapheresis Market Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020, and 2027
  • REST OF WORLD
    • TABLE 130: Rest of World Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020 to 2027
    • TABLE 131: Rest of World Leukapheresis Historic Market Review by Product in US$: 2012-2019
    • TABLE 132: Leukapheresis Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
    • TABLE 133: Rest of World Leukapheresis Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
    • TABLE 134: Leukapheresis Market in Rest of World: Summarization of Historic Demand Patterns in US$ by Application for 2012-2019
    • TABLE 135: Rest of World Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027
    • TABLE 136: Rest of World Leukapheresis Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
    • TABLE 137: Leukapheresis Market in Rest of World: Summarization of Historic Demand Patterns in US$ by End-Use for 2012-2019
    • TABLE 138: Rest of World Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 41